In 38 patients with OSA and anti‐VEGF injections for exudative AMD, the patients with untreated OSA required double the number of injections compared with those treated with CPAP (mean of 16 vs. 8 injections) to reduce the macular oedema. This evidence concerns the gene VEGFA and age-related macular degeneration.